Company
Epiodyne
Creates a full spectrum of precisely calibrated small-molecule opioids tunable for desired therapeutic outcomes.
Also known as EPIODYNE, INC.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Headquarters
- San Francisco, CA, United States
- Legal name
- EPIODYNE, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Based on this platform, our team creates a full spectrum of precisely calibrated small-molecule opioids that are tunable for desired therapeutic outcomes—from full inhibitors to full agonists.
Funding snapshot
- Total raised
- $14.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8M2018-07-10
Funding rounds
- Round, 2018
- $8M2018-07-10, SEC form D sold, 13 investors
- Round, 2017
- $5.8M2017-10-02, SEC form D sold, 3 investors
- Round, 2016
- $500K2016-06-02, SEC form D sold, 2 investors
Loading relationship preview